These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 8614822

  • 21. Stroke: part II. Management of acute ischemic stroke.
    Benavente O, Hart RG.
    Am Fam Physician; 1999 May 15; 59(10):2828-34 concl. PubMed ID: 10348075
    [Abstract] [Full Text] [Related]

  • 22. Alteplase: new indication. Inadequately assessed in ischaemic stroke.
    Prescrire Int; 2004 Aug 15; 13(72):127-31. PubMed ID: 15532135
    [Abstract] [Full Text] [Related]

  • 23. Should thrombolytic therapy be the first-line treatment for acute ischemic stroke? t-PA--the best current option for most patients.
    Grotta J.
    N Engl J Med; 1997 Oct 30; 337(18):1310-3. PubMed ID: 9345085
    [No Abstract] [Full Text] [Related]

  • 24. Rationale for testing thrombolysis in acute ischaemic stroke. MAST Group.
    Hommel M, Cornu C.
    Clin Trials Metaanal; 1993 Nov 30; 28(6):345-56. PubMed ID: 10172266
    [Abstract] [Full Text] [Related]

  • 25. What's new in stroke?
    Hart RG, Benavente O, Lalonde DR, Buell WF.
    Tex Med; 1998 May 30; 94(5):44-9. PubMed ID: 9595952
    [No Abstract] [Full Text] [Related]

  • 26. Mobile BAT gets stroke victims to hospital.
    Telemed Virtual Real; 1998 Mar 30; 3(3):36. PubMed ID: 10177473
    [No Abstract] [Full Text] [Related]

  • 27. Acute ischemic stroke treatment in 2007.
    Goldstein LB.
    Circulation; 2007 Sep 25; 116(13):1504-14. PubMed ID: 17893286
    [No Abstract] [Full Text] [Related]

  • 28. Practical considerations in the early treatment of ischemic stroke.
    Broderick JP.
    Am Fam Physician; 1998 Jan 01; 57(1):73-80. PubMed ID: 9447215
    [Abstract] [Full Text] [Related]

  • 29. Ischaemic stroke: acute-phase drug therapy. Mostly aspirin and heparin.
    Prescrire Int; 2005 Aug 01; 14(78):146-52. PubMed ID: 16106599
    [Abstract] [Full Text] [Related]

  • 30. 20 questions about emergency stroke & cardiac care. Interview by Chad Brocato.
    Gordon DL, Rosenberg D.
    JEMS; 2000 Oct 01; 25(10):22-7, 30. PubMed ID: 11141762
    [No Abstract] [Full Text] [Related]

  • 31. Is it time to definitely abandon neuroprotection in acute ischemic stroke?
    Sacchetti ML.
    Stroke; 2008 Jun 01; 39(6):1659-60. PubMed ID: 18369169
    [No Abstract] [Full Text] [Related]

  • 32. EMS mythology. EMS myth #2. Thombolytic therapy is the standard of care for acute ischemic stroke.
    Bledsoe BE.
    Emerg Med Serv; 2003 Apr 01; 32(4):63-5. PubMed ID: 12705219
    [No Abstract] [Full Text] [Related]

  • 33. Neuroprotection by ketamine: a review of the experimental and clinical evidence.
    Hudetz JA, Pagel PS.
    J Cardiothorac Vasc Anesth; 2010 Feb 01; 24(1):131-42. PubMed ID: 19640746
    [No Abstract] [Full Text] [Related]

  • 34. Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.
    Phillips DA, Fisher M, Davis MA, Smith TW, Pang RH.
    Stroke; 1990 Apr 01; 21(4):602-5. PubMed ID: 2109376
    [Abstract] [Full Text] [Related]

  • 35. [Brain protection in emergency situations: are anesthetics neuroprotective?].
    Hennes HJ, Jantzen JP.
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1997 Sep 01; 32(2 Suppl):S291-5. PubMed ID: 9417248
    [No Abstract] [Full Text] [Related]

  • 36. Stroke. Revolution in therapy.
    Gress DR.
    West J Med; 1994 Sep 01; 161(3):288-91. PubMed ID: 7975568
    [Abstract] [Full Text] [Related]

  • 37. The concept of combination therapy in acute ischemic stroke.
    Sacchetti ML, Toni D, Fiorelli M, Argentino C, Fieschi C.
    Neurology; 1997 Nov 01; 49(5 Suppl 4):S70-4. PubMed ID: 9371156
    [No Abstract] [Full Text] [Related]

  • 38. Current status of neuroprotective agents in the treatment of acute ischemic stroke.
    Lutsep HL, Clark WM.
    Curr Neurol Neurosci Rep; 2001 Jan 01; 1(1):13-8. PubMed ID: 11898495
    [Abstract] [Full Text] [Related]

  • 39. Ischemic strokes arriving too late for tPA are an ideal and ethical control group for continuing studies of tPA efficacy.
    Robinson L.
    Stroke; 1998 Jul 01; 29(7):1476-7. PubMed ID: 9660407
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of cerebrovascular diseases: state of the art and perspectives.
    Toni D, Gallo V, Falcou A, Argentino C, Fieschi C.
    J Cardiovasc Pharmacol; 2001 Nov 01; 38 Suppl 2():S83-6. PubMed ID: 11811386
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.